Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Crude Heparin Market Size(US$)
CAGR 2024-2030
6.2%
Market Size,2030
USD 5,474.4
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 3,818 million
Market Forecast in 2030(Value)
US$ 5,474.4 million
CAGR
6.2%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
The global Crude Heparin market size was US$ 3455 million in 2023 and is forecast to a readjusted size of US$ 5474.4 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Fengrun Biological Technology. The top three players hold a share about 30%. The global crude heparin products are mainly produced in Europe and China. Asia-Pacific is the largest market, has a share about 57%, followed by North America and Europe, with share 21% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 90%.
In terms of sales (consumption) side, this report focuses on the sales of Crude Heparin by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Crude Heparin market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Crude Heparin market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
Market Segmentation
By Company
- Bioiberica
- Shenzhen Hepalink
- Sanofi
- Nanjing King-friend
- Fengrun Biological Technology
- Aspen Oss
- Hebei Changshan Biochemical
- Changzhou Qianhong
- Hepac (Darling Ingredients)
- Huaian MDC Pharmaceutical
- Yantai Dongcheng Biochemicals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
Segment by Application
- UFH
- LMWH
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Crude Heparin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Crude Heparin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crude Heparin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Report Overview
1.1 Crude Heparin Definition
1.2 Market by Type
1.2.1 Global Crude Heparin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Pig Intestine Mucosa Heparin
1.2.3 Bovine Heparin and Others
1.3 Market Segment by Application
1.3.1 Global Crude Heparin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 UFH
1.3.3 LMWH
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Crude Heparin Sales
2.1 Global Crude Heparin Revenue Estimates and Forecasts 2019-2030
2.2 Global Crude Heparin Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Crude Heparin Revenue by Region
2.3.1 Global Crude Heparin Revenue by Region (2019-2024)
2.3.2 Global Crude Heparin Revenue by Region (2025-2030)
2.4 Global Crude Heparin Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Crude Heparin Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Crude Heparin Sales Quantity by Region
2.6.1 Global Crude Heparin Sales Quantity by Region (2019-2024)
2.6.2 Global Crude Heparin Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Crude Heparin Sales Quantity by Manufacturers
3.1.1 Global Crude Heparin Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Crude Heparin Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Crude Heparin Sales in 2023
3.2 Global Crude Heparin Revenue by Manufacturers
3.2.1 Global Crude Heparin Revenue by Manufacturers (2019-2024)
3.2.2 Global Crude Heparin Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Crude Heparin Revenue in 2023
3.3 Global Crude Heparin Sales Price by Manufacturers
3.4 Global Key Players of Crude Heparin, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Crude Heparin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Crude Heparin, Product Offered and Application
3.8 Global Key Manufacturers of Crude Heparin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Crude Heparin Sales Quantity by Type
4.1.1 Global Crude Heparin Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Crude Heparin Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Crude Heparin Sales Quantity Market Share by Type (2019-2030)
4.2 Global Crude Heparin Revenue by Type
4.2.1 Global Crude Heparin Historical Revenue by Type (2019-2024)
4.2.2 Global Crude Heparin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Crude Heparin Revenue Market Share by Type (2019-2030)
4.3 Global Crude Heparin Price by Type
4.3.1 Global Crude Heparin Price by Type (2019-2024)
4.3.2 Global Crude Heparin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Crude Heparin Sales Quantity by Application
5.1.1 Global Crude Heparin Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Crude Heparin Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Crude Heparin Sales Quantity Market Share by Application (2019-2030)
5.2 Global Crude Heparin Revenue by Application
5.2.1 Global Crude Heparin Historical Revenue by Application (2019-2024)
5.2.2 Global Crude Heparin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Crude Heparin Revenue Market Share by Application (2019-2030)
5.3 Global Crude Heparin Price by Application
5.3.1 Global Crude Heparin Price by Application (2019-2024)
5.3.2 Global Crude Heparin Price Forecast by Application (2025-2030)
6 North America
6.1 North America Crude Heparin Sales by Company
6.1.1 North America Crude Heparin Revenue by Company (2019-2024)
6.1.2 North America Crude Heparin Sales Quantity by Company (2019-2024)
6.2 North America Crude Heparin Market Size by Type
6.2.1 North America Crude Heparin Sales Quantity by Type (2019-2030)
6.2.2 North America Crude Heparin Revenue by Type (2019-2030)
6.3 North America Crude Heparin Market Size by Application
6.3.1 North America Crude Heparin Sales Quantity by Application (2019-2030)
6.3.2 North America Crude Heparin Revenue by Application (2019-2030)
6.4 North America Crude Heparin Market Size by Country
6.4.1 North America Crude Heparin Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Crude Heparin Revenue by Country (2019-2030)
6.4.3 North America Crude Heparin Sales Quantity by Country (2019-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Crude Heparin Sales by Company
7.1.1 Europe Crude Heparin Sales Quantity by Company (2019-2024)
7.1.2 Europe Crude Heparin Revenue by Company (2019-2024)
7.2 Europe Crude Heparin Market Size by Type
7.2.1 Europe Crude Heparin Sales Quantity by Type (2019-2030)
7.2.2 Europe Crude Heparin Revenue by Type (2019-2030)
7.3 Europe Crude Heparin Market Size by Application
7.3.1 Europe Crude Heparin Sales Quantity by Application (2019-2030)
7.3.2 Europe Crude Heparin Revenue by Application (2019-2030)
7.4 Europe Crude Heparin Market Size by Country
7.4.1 Europe Crude Heparin Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Crude Heparin Revenue by Country (2019-2030)
7.4.3 Europe Crude Heparin Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Crude Heparin Sales by Company
8.1.1 China Crude Heparin Sales Quantity by Company (2019-2024)
8.1.2 China Crude Heparin Revenue by Company (2019-2024)
8.2 China Crude Heparin Market Size by Type
8.2.1 China Crude Heparin Sales Quantity by Type (2019-2030)
8.2.2 China Crude Heparin Revenue by Type (2019-2030)
8.3 China Crude Heparin Market Size by Application
8.3.1 China Crude Heparin Sales Quantity by Application (2019-2030)
8.3.2 China Crude Heparin Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Crude Heparin Sales by Company
9.1.1 APAC Crude Heparin Sales Quantity by Company (2019-2024)
9.1.2 APAC Crude Heparin Revenue by Company (2019-2024)
9.2 APAC Crude Heparin Market Size by Type
9.2.1 APAC Crude Heparin Sales Quantity by Type (2019-2030)
9.2.2 APAC Crude Heparin Revenue by Type (2019-2030)
9.3 APAC Crude Heparin Market Size by Application
9.3.1 APAC Crude Heparin Sales Quantity by Application (2019-2030)
9.3.2 APAC Crude Heparin Revenue by Application (2019-2030)
9.4 APAC Crude Heparin Market Size by Region
9.4.1 APAC Crude Heparin Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Crude Heparin Revenue by Region (2019-2030)
9.4.3 APAC Crude Heparin Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Crude Heparin Sales by Company
10.1.1 Middle East, Africa and Latin America Crude Heparin Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Crude Heparin Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Crude Heparin Market Size by Type
10.2.1 Middle East, Africa and Latin America Crude Heparin Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Crude Heparin Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Crude Heparin Market Size by Application
10.3.1 Middle East, Africa and Latin America Crude Heparin Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Crude Heparin Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Crude Heparin Market Size by Country
10.4.1 Middle East, Africa and Latin America Crude Heparin Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Crude Heparin Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Crude Heparin Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Bioiberica
11.1.1 Bioiberica Company Information
11.1.2 Bioiberica Overview
11.1.3 Bioiberica Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Bioiberica Crude Heparin Products and Services
11.1.5 Bioiberica Crude Heparin SWOT Analysis
11.1.6 Bioiberica Recent Developments
11.2 Shenzhen Hepalink
11.2.1 Shenzhen Hepalink Company Information
11.2.2 Shenzhen Hepalink Overview
11.2.3 Shenzhen Hepalink Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Shenzhen Hepalink Crude Heparin Products and Services
11.2.5 Shenzhen Hepalink Crude Heparin SWOT Analysis
11.2.6 Shenzhen Hepalink Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Sanofi Crude Heparin Products and Services
11.3.5 Sanofi Crude Heparin SWOT Analysis
11.3.6 Sanofi Recent Developments
11.4 Nanjing King-friend
11.4.1 Nanjing King-friend Company Information
11.4.2 Nanjing King-friend Overview
11.4.3 Nanjing King-friend Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Nanjing King-friend Crude Heparin Products and Services
11.4.5 Nanjing King-friend Crude Heparin SWOT Analysis
11.4.6 Nanjing King-friend Recent Developments
11.5 Fengrun Biological Technology
11.5.1 Fengrun Biological Technology Company Information
11.5.2 Fengrun Biological Technology Overview
11.5.3 Fengrun Biological Technology Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Fengrun Biological Technology Crude Heparin Products and Services
11.5.5 Fengrun Biological Technology Crude Heparin SWOT Analysis
11.5.6 Fengrun Biological Technology Recent Developments
11.6 Aspen Oss
11.6.1 Aspen Oss Company Information
11.6.2 Aspen Oss Overview
11.6.3 Aspen Oss Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Aspen Oss Crude Heparin Products and Services
11.6.5 Aspen Oss Crude Heparin SWOT Analysis
11.6.6 Aspen Oss Recent Developments
11.7 Hebei Changshan Biochemical
11.7.1 Hebei Changshan Biochemical Company Information
11.7.2 Hebei Changshan Biochemical Overview
11.7.3 Hebei Changshan Biochemical Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Hebei Changshan Biochemical Crude Heparin Products and Services
11.7.5 Hebei Changshan Biochemical Crude Heparin SWOT Analysis
11.7.6 Hebei Changshan Biochemical Recent Developments
11.8 Changzhou Qianhong
11.8.1 Changzhou Qianhong Company Information
11.8.2 Changzhou Qianhong Overview
11.8.3 Changzhou Qianhong Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.8.4 Changzhou Qianhong Crude Heparin Products and Services
11.8.5 Changzhou Qianhong Crude Heparin SWOT Analysis
11.8.6 Changzhou Qianhong Recent Developments
11.9 Hepac (Darling Ingredients)
11.9.1 Hepac (Darling Ingredients) Company Information
11.9.2 Hepac (Darling Ingredients) Overview
11.9.3 Hepac (Darling Ingredients) Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.9.4 Hepac (Darling Ingredients) Crude Heparin Products and Services
11.9.5 Hepac (Darling Ingredients) Crude Heparin SWOT Analysis
11.9.6 Hepac (Darling Ingredients) Recent Developments
11.10 Huaian MDC Pharmaceutical
11.10.1 Huaian MDC Pharmaceutical Company Information
11.10.2 Huaian MDC Pharmaceutical Overview
11.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.10.4 Huaian MDC Pharmaceutical Crude Heparin Products and Services
11.10.5 Huaian MDC Pharmaceutical Crude Heparin SWOT Analysis
11.10.6 Huaian MDC Pharmaceutical Recent Developments
11.11 Yantai Dongcheng Biochemicals
11.11.1 Yantai Dongcheng Biochemicals Company Information
11.11.2 Yantai Dongcheng Biochemicals Overview
11.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.11.4 Yantai Dongcheng Biochemicals Crude Heparin Products and Services
11.11.5 Yantai Dongcheng Biochemicals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Crude Heparin Value Chain Analysis
12.2 Crude Heparin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Crude Heparin Production Mode & Process
12.4 Crude Heparin Sales and Marketing
12.4.1 Crude Heparin Sales Channels
12.4.2 Crude Heparin Distributors
12.5 Crude Heparin Customers
13 Market Dynamics
13.1 Crude Heparin Industry Trends
13.2 Crude Heparin Market Drivers
13.3 Crude Heparin Market Challenges
13.4 Crude Heparin Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Crude Heparin Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Pig Intestine Mucosa Heparin
Table 3. Major Manufacturers of Bovine Heparin and Others
Table 4. Global Crude Heparin Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Crude Heparin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Crude Heparin Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Crude Heparin Revenue Market Share by Region (2019-2024)
Table 8. Global Crude Heparin Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Crude Heparin Revenue Market Share by Region (2025-2030)
Table 10. Global Crude Heparin Sales Quantity by Region: 2019 VS 2023 VS 2030 (Tons)
Table 11. Global Crude Heparin Sales by Region (2019-2024) & (Tons)
Table 12. Global Crude Heparin Sales Market Share by Region (2019-2024)
Table 13. Global Crude Heparin Sales by Region (2025-2030) & (Tons)
Table 14. Global Crude Heparin Sales Market Share by Region (2025-2030)
Table 15. Global Crude Heparin Sales Quantity by Manufacturers (2019-2024) & (Tons)
Table 16. Global Crude Heparin Sales Quantity Share by Manufacturers (2019-2024)
Table 17. Global Crude Heparin Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Crude Heparin Revenue Share by Manufacturers (2019-2024)
Table 19. Global Crude Heparin Price by Manufacturers 2019-2024 (US$/Kg)
Table 20. Global Key Players of Crude Heparin, Industry Ranking, 2022 VS 2023
Table 21. Global Crude Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Crude Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crude Heparin as of 2023)
Table 23. Global Key Manufacturers of Crude Heparin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Crude Heparin, Product Offered and Application
Table 25. Global Key Manufacturers of Crude Heparin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Crude Heparin Sales Quantity by Type (2019-2024) & (Tons)
Table 28. Global Crude Heparin Sales Quantity by Type (2025-2030) & (Tons)
Table 29. Global Crude Heparin Sales Quantity Share by Type (2019-2024)
Table 30. Global Crude Heparin Sales Quantity Share by Type (2025-2030)
Table 31. Global Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Crude Heparin Revenue Share by Type (2019-2024)
Table 34. Global Crude Heparin Revenue Share by Type (2025-2030)
Table 35. Crude Heparin Price by Type (2019-2024) & (US$/Kg)
Table 36. Global Crude Heparin Price Forecast by Type (2025-2030) & (US$/Kg)
Table 37. Global Crude Heparin Sales Quantity by Application (2019-2024) & (Tons)
Table 38. Global Crude Heparin Sales Quantity by Application (2025-2030) & (Tons)
Table 39. Global Crude Heparin Sales Quantity Share by Application (2019-2024)
Table 40. Global Crude Heparin Sales Quantity Share by Application (2025-2030)
Table 41. Global Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Crude Heparin Revenue Share by Application (2019-2024)
Table 44. Global Crude Heparin Revenue Share by Application (2025-2030)
Table 45. Crude Heparin Price by Application (2019-2024) & (US$/Kg)
Table 46. Global Crude Heparin Price Forecast by Application (2025-2030) & (US$/Kg)
Table 47. North America Crude Heparin Revenue by Company (2019-2024) & (US$ Million)
Table 48. North America Crude Heparin Sales Quantity by Company (2019-2024) & (Tons)
Table 49. North America Crude Heparin Sales Quantity by Type (2019-2024) & (Tons)
Table 50. North America Crude Heparin Sales Quantity by Type (2025-2030) & (Tons)
Table 51. North America Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 52. North America Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 53. North America Crude Heparin Sales Quantity by Application (2019-2024) & (Tons)
Table 54. North America Crude Heparin Sales Quantity by Application (2025-2030) & (Tons)
Table 55. North America Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 56. North America Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 57. North America Crude Heparin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. North America Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 59. North America Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 60. North America Crude Heparin Sales Quantity by Country (2019-2024) & (Tons)
Table 61. North America Crude Heparin Sales Quantity by Country (2025-2030) & (Tons)
Table 62. Europe Crude Heparin Sales Quantity by Company (2019-2024) & (Tons)
Table 63. Europe Crude Heparin Revenue by Company (2019-2024) & (US$ Million)
Table 64. Europe Crude Heparin Sales Quantity by Type (2019-2024) & (Tons)
Table 65. Europe Crude Heparin Sales Quantity by Type (2025-2030) & (Tons)
Table 66. Europe Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 67. Europe Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 68. Europe Crude Heparin Sales Quantity by Application (2019-2024) & (Tons)
Table 69. Europe Crude Heparin Sales Quantity by Application (2025-2030) & (Tons)
Table 70. Europe Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 71. Europe Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 72. Europe Crude Heparin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 73. Europe Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 74. Europe Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 75. Europe Crude Heparin Sales Quantity by Country (2019-2024) & (Tons)
Table 76. Europe Crude Heparin Sales Quantity by Country (2025-2030) & (Tons)
Table 77. China Crude Heparin Sales Quantity by Company (2019-2024) & (Tons)
Table 78. China Crude Heparin Revenue by Company (2019-2024) & (US$ Million)
Table 79. China Crude Heparin Sales Quantity by Type (2019-2024) & (Tons)
Table 80. China Crude Heparin Sales Quantity by Type (2025-2030) & (Tons)
Table 81. China Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 82. China Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 83. China Crude Heparin Sales Quantity by Application (2019-2024) & (Tons)
Table 84. China Crude Heparin Sales Quantity by Application (2025-2030) & (Tons)
Table 85. China Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 86. China Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 87. APAC Crude Heparin Sales Quantity by Company (2019-2024) & (Tons)
Table 88. APAC Crude Heparin Revenue by Company (2019-2024) & (US$ Million)
Table 89. APAC Crude Heparin Sales Quantity by Type (2019-2024) & (Tons)
Table 90. APAC Crude Heparin Sales Quantity by Type (2025-2030) & (Tons)
Table 91. APAC Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 92. APAC Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 93. APAC Crude Heparin Sales Quantity by Application (2019-2024) & (Tons)
Table 94. APAC Crude Heparin Sales Quantity by Application (2025-2030) & (Tons)
Table 95. APAC Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 96. APAC Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 97. APAC Crude Heparin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 98. APAC Crude Heparin Revenue by Region (2019-2024) & (US$ Million)
Table 99. APAC Crude Heparin Revenue by Region (2025-2030) & (US$ Million)
Table 100. APAC Crude Heparin Sales Quantity by Region (2019-2024) & (Tons)
Table 101. APAC Crude Heparin Sales Quantity by Region (2025-2030) & (Tons)
Table 102. Middle East, Africa and Latin America Crude Heparin Sales Quantity by Company (2019-2024) & (Tons)
Table 103. Middle East, Africa and Latin America Crude Heparin Revenue by Company (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Crude Heparin Sales Quantity by Type (2019-2024) & (Tons)
Table 105. Middle East, Africa and Latin America Crude Heparin Sales Quantity by Type (2025-2030) & (Tons)
Table 106. Middle East, Africa and Latin America Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Crude Heparin Sales Quantity by Application (2019-2024) & (Tons)
Table 109. Middle East, Africa and Latin America Crude Heparin Sales Quantity by Application (2025-2030) & (Tons)
Table 110. Middle East, Africa and Latin America Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 112. Middle East, Africa and Latin America Crude Heparin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 113. Middle East, Africa and Latin America Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 115. Middle East, Africa and Latin America Crude Heparin Sales Quantity by Country (2019-2024) & (Tons)
Table 116. Middle East, Africa and Latin America Crude Heparin Sales Quantity by Country (2025-2030) & (Tons)
Table 117. Bioiberica Company Information
Table 118. Bioiberica Description and Overview
Table 119. Bioiberica Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 120. Bioiberica Crude Heparin Product and Services
Table 121. Bioiberica Crude Heparin SWOT Analysis
Table 122. Bioiberica Recent Developments
Table 123. Shenzhen Hepalink Company Information
Table 124. Shenzhen Hepalink Description and Overview
Table 125. Shenzhen Hepalink Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 126. Shenzhen Hepalink Crude Heparin Product and Services
Table 127. Shenzhen Hepalink Crude Heparin SWOT Analysis
Table 128. Shenzhen Hepalink Recent Developments
Table 129. Sanofi Company Information
Table 130. Sanofi Description and Overview
Table 131. Sanofi Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 132. Sanofi Crude Heparin Product and Services
Table 133. Sanofi Crude Heparin SWOT Analysis
Table 134. Sanofi Recent Developments
Table 135. Nanjing King-friend Company Information
Table 136. Nanjing King-friend Description and Overview
Table 137. Nanjing King-friend Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 138. Nanjing King-friend Crude Heparin Product and Services
Table 139. Nanjing King-friend Crude Heparin SWOT Analysis
Table 140. Nanjing King-friend Recent Developments
Table 141. Fengrun Biological Technology Company Information
Table 142. Fengrun Biological Technology Description and Overview
Table 143. Fengrun Biological Technology Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 144. Fengrun Biological Technology Crude Heparin Product and Services
Table 145. Fengrun Biological Technology Crude Heparin SWOT Analysis
Table 146. Fengrun Biological Technology Recent Developments
Table 147. Aspen Oss Company Information
Table 148. Aspen Oss Description and Overview
Table 149. Aspen Oss Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 150. Aspen Oss Crude Heparin Product and Services
Table 151. Aspen Oss Crude Heparin SWOT Analysis
Table 152. Aspen Oss Recent Developments
Table 153. Hebei Changshan Biochemical Company Information
Table 154. Hebei Changshan Biochemical Description and Overview
Table 155. Hebei Changshan Biochemical Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 156. Hebei Changshan Biochemical Crude Heparin Product and Services
Table 157. Hebei Changshan Biochemical Crude Heparin SWOT Analysis
Table 158. Hebei Changshan Biochemical Recent Developments
Table 159. Changzhou Qianhong Company Information
Table 160. Changzhou Qianhong Description and Overview
Table 161. Changzhou Qianhong Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 162. Changzhou Qianhong Crude Heparin Product and Services
Table 163. Changzhou Qianhong Crude Heparin SWOT Analysis
Table 164. Changzhou Qianhong Recent Developments
Table 165. Hepac (Darling Ingredients) Company Information
Table 166. Hepac (Darling Ingredients) Description and Overview
Table 167. Hepac (Darling Ingredients) Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 168. Hepac (Darling Ingredients) Crude Heparin Product and Services
Table 169. Hepac (Darling Ingredients) Crude Heparin SWOT Analysis
Table 170. Hepac (Darling Ingredients) Recent Developments
Table 171. Huaian MDC Pharmaceutical Company Information
Table 172. Huaian MDC Pharmaceutical Description and Overview
Table 173. Huaian MDC Pharmaceutical Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 174. Huaian MDC Pharmaceutical Crude Heparin Product and Services
Table 175. Huaian MDC Pharmaceutical Crude Heparin SWOT Analysis
Table 176. Huaian MDC Pharmaceutical Recent Developments
Table 177. Yantai Dongcheng Biochemicals Company Information
Table 178. Yantai Dongcheng Biochemicals Description and Overview
Table 179. Yantai Dongcheng Biochemicals Crude Heparin Sales Quantity (Tons), Revenue (US$ Million), Average Selling Price (ASP) (US$/Kg) and Gross Margin (2019-2024)
Table 180. Yantai Dongcheng Biochemicals Crude Heparin Product and Services
Table 181. Yantai Dongcheng Biochemicals Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Crude Heparin Distributors List
Table 185. Crude Heparin Customers List
Table 186. Crude Heparin Market Trends
Table 187. Crude Heparin Market Drivers
Table 188. Crude Heparin Market Challenges
Table 189. Crude Heparin Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Crude Heparin Product Picture
Figure 2. Global Crude Heparin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Crude Heparin Market Share by Type in 2023 & 2030
Figure 4. Pig Intestine Mucosa Heparin Product Picture
Figure 5. Bovine Heparin and Others Product Picture
Figure 6. Global Crude Heparin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Crude Heparin Market Share by Application in 2023 & 2030
Figure 8. UFH
Figure 9. LMWH
Figure 10. Crude Heparin Report Years Considered
Figure 11. Global Crude Heparin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Crude Heparin Revenue 2019-2030 (US$ Million)
Figure 13. Global Crude Heparin Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Crude Heparin Sales Quantity 2019-2030 (Tons)
Figure 15. Global Crude Heparin Sales Quantity Market Share by Region (2019-2024)
Figure 16. Global Crude Heparin Sales Quantity Market Share by Region (2025-2030)
Figure 17. North America Crude Heparin Sales Quantity YoY (2019-2030) & (Tons)
Figure 18. North America Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Crude Heparin Sales Quantity YoY (2019-2030) & (Tons)
Figure 20. Europe Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Crude Heparin Sales Quantity YoY (2019-2030) & (Tons)
Figure 22. China Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 23. APAC Crude Heparin Sales Quantity YoY (2019-2030) & (Tons)
Figure 24. APAC Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Crude Heparin Sales Quantity YoY (2019-2030) & (Tons)
Figure 26. Middle East, Africa and Latin America Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Crude Heparin Sales Quantity in 2023
Figure 28. The Top 10 and Top 5 Players Market Share by Crude Heparin Revenue in 2023
Figure 29. Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Crude Heparin Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 32. Global Crude Heparin Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 34. North America Crude Heparin Revenue Market Share by Company in 2023
Figure 35. North America Crude Heparin Sales Quantity Market Share by Company in 2023
Figure 36. North America Crude Heparin Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 38. North America Crude Heparin Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 40. North America Crude Heparin Revenue Share by Country (2019-2030)
Figure 41. North America Crude Heparin Sales Quantity Share by Country (2019-2030)
Figure 42. United States Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Crude Heparin Sales Quantity Market Share by Company in 2023
Figure 45. Europe Crude Heparin Revenue Market Share by Company in 2023
Figure 46. Europe Crude Heparin Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 48. Europe Crude Heparin Sales Quantity Market Share by Application (2019-2030)
Figure 49. Europe Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 50. Europe Crude Heparin Revenue Share by Country (2019-2030)
Figure 51. Europe Crude Heparin Sales Quantity Share by Country (2019-2030)
Figure 52. Germany Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 53. France Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 54. U.K. Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 55. Italy Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 56. Russia Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 57. China Crude Heparin Sales Quantity Market Share by Company in 2023
Figure 58. China Crude Heparin Revenue Market Share by Company in 2023
Figure 59. China Crude Heparin Sales Quantity Market Share by Type (2019-2030)
Figure 60. China Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 61. China Crude Heparin Sales Quantity Market Share by Application (2019-2030)
Figure 62. China Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 63. APAC Crude Heparin Sales Quantity Market Share by Company in 2023
Figure 64. APAC Crude Heparin Revenue Market Share by Company in 2023
Figure 65. APAC Crude Heparin Sales Quantity Market Share by Type (2019-2030)
Figure 66. APAC Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 67. APAC Crude Heparin Sales Quantity Market Share by Application (2019-2030)
Figure 68. APAC Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 69. APAC Crude Heparin Revenue Share by Region (2019-2030)
Figure 70. APAC Crude Heparin Sales Quantity Share by Region (2019-2030)
Figure 71. Japan Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 72. South Korea Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 73. China Taiwan Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 74. Southeast Asia Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 75. India Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Crude Heparin Sales Quantity Market Share by Company in 2023
Figure 77. Middle East, Africa and Latin America Crude Heparin Revenue Market Share by Company in 2023
Figure 78. Middle East, Africa and Latin America Crude Heparin Sales Quantity Market Share by Type (2019-2030)
Figure 79. Middle East, Africa and Latin America Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 80. Middle East, Africa and Latin America Crude Heparin Sales Quantity Market Share by Application (2019-2030)
Figure 81. Middle East, Africa and Latin America Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 82. Middle East, Africa and Latin America Crude Heparin Sales Quantity Share by Country (2019-2030)
Figure 83. Middle East, Africa and Latin America Crude Heparin Revenue Share by Country (2019-2030)
Figure 84. Brazil Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 85. Mexico Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 86. Turkey Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 87. Israel Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 88. GCC Countries Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 89. Crude Heparin Value Chain
Figure 90. Crude Heparin Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
Related Reports
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-07
Pages: 108
USD 4900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-16
Pages: 147
USD 5900.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 128
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-18
Pages: 88
USD 2900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 164
USD 4900.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 112
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 124
USD 2900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 95
USD 4250.00
(Single User License)
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-07
Pages: 108
USD 4900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-16
Pages: 147
USD 5900.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 128
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-18
Pages: 88
USD 2900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
USD 5900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
USD 4250.00 (Single User License)Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 164
USD 4900.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 112
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 124
USD 2900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 95
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research